| abstract |
The invention relates to processes and intermediates for making {1- {1- [3-fluoro-2- (trifluoromethyl) isonicotinoyl] piperidin-4-yl} -3- [4- (7H-pyrrolo [2,3-d ] pyrimidin-4-yl) -1H-pyrazol-1-yl] azetidin-3-yl} acetonitrile, which has formula (I), useful in the treatment of diseases related to Janus kinase activity (JAK) including disorders inflammatory, autoimmune disorders, cancer and other diseases |